It was reported on Tuesday that CATO SMS, a company focused on specialised clinical research solutions, has acquired United States-based Array Biostatistics.
This move is to help CATO SMS expand its full-service biostatistical consulting, analysis and programming capabilities. CATO SMS is to concentrate on building its team of senior biostaticians and statistical programmers as part of its expansion plans.
Array will continue to be led by Sandy Ferber, chief executive officer of Array. Ferber will also lead CATO SMS' overall biometrics offering.
Sanofi's efdoralprin alfa receives EU orphan designation for AATD-related emphysema
Alcami completes third sterile fill-finish line at Research Triangle Park, NC
Black Buffalo partners with Sanova to support regulatory strategy and scientific innovation
Neurocrine Biosciences reveals new chapter in R&D strategy
Nicox completes key data package for NCX 470 NDA submissions
Immusoft's ISP-002 granted US FDA Orphan Drug Designation in MPS II
Orphan Therapeutics Accelerator signs MoU with Fondazione Telethon
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Physiomics secures follow-on UK contract for Phase 2 study support
Ascletis reports positive US Phase I data for oral IL-17 inhibitor ASC50
Dimerix completes adult recruitment in ACTION3 Phase 3 DMX-200 trial
RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL
Vanda files FDA Biologics License Application for imsidolimab in generalized pustular psoriasis
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
Sobi s Aspaveli marketing authorisation receives positive European regulatory opinion